Sayfa yüklenirken bir hata oluştu.
Teknik ekibimiz bilgilendirildi, ancak sorunun devam etmesi durumunda lütfen e-posta destek widget ile bize ulaşın.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM EBIT Multiple | -28,4x - -31,4x | -29,9x |
| Selected Fwd EBIT Multiple | 17,2x - 19,0x | 18,1x |
| Fair Value | €1,06 - €1,22 | €1,14 |
| Upside | -16,6% - -4,0% | -10,3% |
| Benchmarks | Ticker | Full Ticker |
| DexCom, Inc. | DXCM | NasdaqGS:DXCM |
| MicroTech Medical (Hangzhou) Co., Ltd. | 2235 | SEHK:2235 |
| Shandong Weigao Group Medical Polymer Company Limited | 1066 | SEHK:1066 |
| Corentec Co., Ltd. | A104540 | KOSDAQ:A104540 |
| United Orthopedic Corporation | 4129 | TPEX:4129 |
| MicroPort Scientific Corporation | MSK | DB:MSK |
| - | - | - |
| Select LTM EBIT Multiple | |||||||
| Benchmark Companies | |||||||
| DXCM | 2235 | 1066 | A104540 | 4129 | MSK | ||
| NasdaqGS:DXCM | SEHK:2235 | SEHK:1066 | KOSDAQ:A104540 | TPEX:4129 | DB:MSK | ||
| Historical EBIT Growth | |||||||
| 5Y CAGR | 33.3% | NM- | -0.3% | 0.0% | 49.9% | NM- | |
| 3Y CAGR | 31.2% | NM- | -8.9% | -4.5% | 55.7% | NM- | |
| Latest Twelve Months | 0.8% | 24.5% | 5.8% | 19.1% | 11.1% | 60.9% | |
| Historical EBIT Profit Margin | |||||||
| 5 Year Average Margin | 14.3% | -70.0% | 19.7% | 7.7% | 9.9% | -33.2% | |
| Prior Fiscal Year | 16.5% | -77.1% | 16.5% | 7.6% | 13.8% | -26.8% | |
| Latest Fiscal Year | 14.9% | -42.7% | 17.4% | 3.5% | 13.1% | -9.7% | |
| Latest Twelve Months | 16.0% | -42.7% | 16.7% | 5.6% | 13.3% | -9.7% | |
| Current Trading Multiples | |||||||
| EV / LTM Revenue | 6.76x | 3.43x | 1.52x | 0.95x | 2.28x | 3.76x | |
| EV / LTM EBITDA | 31.5x | -8.7x | 6.4x | 8.2x | 10.3x | 1302.3x | |
| EV / LTM EBIT | 42.3x | -8.1x | 9.1x | 17.0x | 17.2x | -38.9x | |
| Low | Mid | High | |||||
| Benchmark EV / LTM EBIT | -8.1x | 17.0x | 42.3x | ||||
| Historical EV / LTM EBIT | -77.0x | -22.1x | -7.6x | ||||
| Selected EV / LTM EBIT | -28.4x | -29.9x | -31.4x | ||||
| (x) LTM EBIT | (100) | (100) | (100) | ||||
| (=) Implied Enterprise Value | 2,833 | 2,982 | 3,131 | ||||
| (-) Non-shareholder Claims * | (1,006) | (1,006) | (1,006) | ||||
| (=) Equity Value | 1,827 | 1,976 | 2,125 | ||||
| (/) Shares Outstanding | 1,902.9 | 1,902.9 | 1,902.9 | ||||
| Implied Value Range | 0.96 | 1.04 | 1.12 | ||||
| FX Rate: USD/EUR | 1.2 | 1.2 | 1.2 | Market Price | |||
| Implied Value Range (Trading Cur) | 0.82 | 0.89 | 0.96 | 1.27 | |||
| Upside / (Downside) | -35.3% | -30.0% | -24.7% | ||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | DXCM | 2235 | 1066 | A104540 | 4129 | MSK | |
| Enterprise Value | 28,977 | 1,142 | 19,963 | 94,688 | 11,654 | 3,830 | |
| (+) Cash & Short Term Investments | 2,929 | 1,707 | 9,652 | 35,550 | 528 | 828 | |
| (+) Investments & Other | 116 | 0 | 2,111 | 4,525 | 371 | 393 | |
| (-) Debt | (2,579) | (0) | (5,513) | (52,376) | (1,459) | (1,685) | |
| (-) Other Liabilities | 0 | 0 | (1,590) | (9,708) | (100) | (541) | |
| (-) Preferred Stock | 0 | 0 | 0 | (1,974) | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 29,443 | 2,849 | 24,623 | 70,705 | 10,994 | 2,824 | |
| (/) Shares Outstanding | 392.2 | 418.6 | 4,561.8 | 12.8 | 96.4 | 1,902.9 | |
| Implied Stock Price | 75.08 | 6.81 | 5.40 | 5,530.00 | 114.00 | 1.48 | |
| FX Conversion Rate to Trading Currency | 1.00 | 0.91 | 0.91 | 1.00 | 1.00 | 1.17 | |
| Implied Stock Price (Trading Cur) | 75.08 | 7.44 | 5.90 | 5,530.00 | 114.00 | 1.27 | |
| Trading Currency | USD | HKD | HKD | KRW | TWD | EUR | |
| FX Rate to Reporting Currency | 1.00 | 0.91 | 0.91 | 1.00 | 1.00 | 1.17 | |